Growth Dynamics of U.S. Home Infusion Therapy Market with Terumo Medical Corporation, Becton Dickinson, Baxter Halyard Health, International Inc.

The U.S. Home Infusion Therapy Market is set to exceed USD 13.5 billion by 2024; according to a new research report by Global Market Insights. Increasing rates of hospital acquired infections have impacted the market growth positively. In American hospitals, infections associated with health care account for around 1.7 million infections and 99,000 deaths every year. These infections lead to chronic diseases that require continuous monitoring; thus, accelerate demand for home infusion therapies.

Request for a sample of this research report @ https://www.gminsights.com/request-sample/detail/2641

Infusion pump segment held around 51% in market share in 2017 and is estimated to grow at a CAGR of 9.8% over the forecast timeline. Growth is attributed to modifications incorporated in infusion pumps that have reduced errors while administering the fluids in patient’s body. Rising prevalence of diseases and surgical procedures have escalated demand for infusion pumps.
Needleless connectors segment will grow at a CAGR of 10.5% over the forecast period due to growing demand for hydration therapies and rising prevalence of diseases such as malaria, dengue and others that requires continuous supply of fluids. Patients suffering from chronic conditions require continuous supply of medical accessories such as needleless connectors thereby will accelerate business growth over the forecast timeframe.

Company profiled in this report based on Business overview, Financial data, Product landscape, Strategic outlook & SWOT analysis:
• Halyard Health
• ICU Medical
• Amsino International Inc.
• BKK B. Braun Melsungen AG
• CME (Caesarea Medical Electronics Ltd.)
• Baxter International Inc.
• Smiths Medical
• Terumo Medical Corporation
• Becton Dickinson
• Fresenius Kabi USA

Anti-infectives accounted for over 27.5% market share in 2017 and is anticipated to continue dominating the industry over the upcoming years. Growing rates of bacterial, viral and other infections coupled with rising rates of hospital acquired infections escalate the demand for anti-infectives therapy enhancing overall industry growth.

Parenteral nutrition segment will witness lucrative growth over the coming years owing to increasing demand for home infusion therapies. Around 40,000 people in U.S. receive home parenteral nutrition safely through variety of catheters. The therapeutic benefits as well as treatment against poor functioning of gastro-intestinal tract disorders through parenteral nutrition should propel its demand over the forecast timeframe.

Make an inquiry for purchasing this report @ https://www.gminsights.com/inquiry-before-buying/2641

South Atlantic home infusion therapy market is anticipated to witness significant growth over the coming years owing to rising prevalence of nosocomial infections and chronic diseases. Increasing geriatric population, prone to infections due to reduced immunity will further boost industry growth. Also, growing rates of surgical procedures will have positive impact on the market demand.

U.S. Home Infusion Therapy Market by Product
o Infusion pump
o Intravenous sets
o IV cannulas
o Needleless connectors

U.S. Home Infusion Therapy Market by Application
o Anti-infectives
o Hydration therapy
o Chemotherapy
o Enteral nutrition
o Parenteral nutrition
o Specialty pharmaceuticals

Global Market Insights Inc. is a global market research and management consulting company catering to leading corporations, non-profit organizations, universities and government institutions. Our main goal is to assist and partner organizations to make lasting strategic improvements and realize growth targets. Our industry research reports are designed to provide granular quantitative information, combined with key industry insights, aimed at assisting sustainable organizational development.

Global Market Insights, Inc.
4 North Main Street
Selbyville, Delaware 19975 USA
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email:sales@gminsights.com

This release was published on openPR.